B. Sallerin-Caute

Chronic intrathecal baclofen administration for control of severe spasticity.

Y. Lazorthes, B. Sallerin-Caute, J. Verdié, 1990, Journal of neurosurgery.

Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance?

O. Déguine, Y. Lazorthes, B. Francés, 1998, Neurosurgery.

Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM

M. Tauber, J. Tauber, H. Hanaire-Broutin, 1996, Diabetologia.

CSF Baclofen levels after intrathecal administration in severe spasticity

B. Monsarrat, Y. Lazorthes, B. Sallerin-Caute, 2004, European Journal of Clinical Pharmacology.

Advances in drug delivery systems and applications in neurosurgery.

Y. Lazorthes, B. Sallerin-Caute, J. Verdié, 1991, Advances and technical standards in neurosurgery.

Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children.

B. Sallerin-Caute, R. Bastide, M. Tauber, 1993, The Journal of clinical endocrinology and metabolism.

Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization.

M. Tauber, J. Tauber, H. Hanaire-Broutin, 1996, Diabetes & metabolism.

A Sensitive Method for the Determination of Baclofen in Human CSF by High Performance Liquid Chromatography

B. Monsarrat, Y. Lazorthes, B. Sallerin-Caute, 1988 .

Intrathecal infusion of Baclofen for spasticity: the Toulouse and the French Multicenter Studies

Y. Lazorthes, B. Sallerin-Caute, J. Verdié, 1991 .